Clinical trials
Completed Papillomavirus Infections trials with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
76 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 3 |
| 2008 | 1 |
| 2009 | 3 |
| 2010 | 1 |
| 2011 | 4 |
| 2012 | 4 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 3 |
| 2016 | 4 |
| 2017 | 3 |
| 2018 | 7 |
| 2019 | 4 |
| 2020 | 7 |
| 2021 | 4 |
| 2022 | 7 |
| 2023 | 4 |
| 2024 | 7 |
| 2025 | 3 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 76 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Duke University | 3 |
| Procare Health Iberia S.L. | 3 |
| University of California, Los Angeles | 3 |
| Centre Hospitalier Universitaire de Besancon | 2 |
| Istanbul University - Cerrahpasa | 2 |
| Ohio State University Comprehensive Cancer Center | 2 |
| University Hospital, Geneva | 2 |
| University of Utah | 2 |
| AGUNCO Obstetrics and Gynecology Centre | 1 |
| AIDS Malignancy Consortium | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Papillomavirus Infections | 76 |
| Uterine Cervical Neoplasms | 27 |
| Uterine Cervical Dysplasia | 9 |
| HIV Infections | 5 |
| Neoplasms | 5 |
| Anus Neoplasms | 4 |
| Infections | 3 |
| Atypical Squamous Cells of the Cervix | 2 |
| Oropharyngeal Neoplasms | 2 |
| Penile Neoplasms | 2 |
Trials
Showing 1 to 25 of 76. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.